Gammaretrovirus associated with cancer
Details for Australian Patent Application No. 2006235266 (hide)
International Classifications
Event Publications
25 October 2007 PCT application entered the National Phase
PCT publication WO2006/110589 Priority application(s): WO2006/110589
20 December 2007 Amendment Made
The nature of the amendment is as shown in the statement(s) filed 26 Nov 2007
13 March 2008 Section 223 Application Received
The Regents of the University of California; The Cleveland Clinic Foundation An application to extend the time from 19 Oct 2006 to 19 Dec 2007 in which to comply with section 6(c) has been filed . Address for service in Australia - Davies Collison Cave 1 Nicholson Street Melbourne VIC 3000 2007
1 May 2008 Section 223 Application Allowed
The Regents of the University of California; The Cleveland Clinic Foundation The time in which to comply with section 6(c) has been extended to 19 Dec 2007. Address for service in Australia - Davies Collison Cave 1 Nicholson Street Melbourne VIC 3000
23 December 2010 Application Accepted
Published as AU-B-2006235266
26 May 2011 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2006235271-SEMA4D in cancer diagnosis, detection and treatment
2006235264-DDR2 in cancer diagnosis, detection and treatment
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional

- Editable Word format reports
- For IP Professionals
- Multiuser